Latest Nura Bio News & Updates

See the latest news and media coverage for Nura Bio. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Nura Bio

Neuroprotective therapies developer

nurabio.com
Headquarters
South San Francisco, United States
Founded year
2018
Company type
Private company
Number of employees
30–50

Last updated

Latest news about Nura Bio

In short: Nura Bio transitioned to a clinical-stage company, raised $140M in total Series A funding, and expanded its executive leadership team.

Company announcements

Nura Bio

Nura Bio appoints C-suite executives

Lahar Mehta, M.D. as Chief Medical Officer and Scott Greenberg as Chief Business Officer to advance clinical pipeline.

Nura Bio

Nura Bio initiates Phase 1 trial for NB-4746

NB-4746 is an oral, brain-penetrant SARM1 inhibitor for neurological diseases like ALS and MS. This marks Nura Bio's transition to a clinical-stage company.

Unlock all announcements with a

Media coverage

BioWorld

Nura Bio presents new SARM1 inhibitors for neurological disorders

BioWorld - Monday, October 7, 2024 Breaking News: BioWorld celebrates nine wins at 2024 APEX Awards See today's BioWorld Science Home » Nura Bio presents...

Unlock all articles with a

Never miss news about Nura Bio

Track Nura Bio and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Nura Bio competitors & trending companies

Browse news for competitors to Nura Bio and other trending companies.